Dingdang Health Technology Group Ltd. disclosed that it repurchased 217,000 ordinary shares on 25 March 2026 via on-market transactions at HKD 0.83–0.85 per share, spending HKD 0.18 million in aggregate.
The transaction forms part of the buyback mandate approved on 28 May 2025, which authorises the company to repurchase up to 131.95 million shares. Including the latest purchase, Dingdang Health has bought back 24.89 million shares, equivalent to 1.89 % of the issued share capital on the mandate date.
Despite the ongoing repurchases, the issued share count remains unchanged at 1,319.47 million shares as of 25 March 2026 because the repurchased shares have not yet been cancelled. The company is subject to a moratorium on issuing or announcing new share issues until 24 April 2026 under Hong Kong listing rules.
Comments